252 related articles for article (PubMed ID: 30401548)
21. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
El Khoudary SR; Aggarwal B; Beckie TM; Hodis HN; Johnson AE; Langer RD; Limacher MC; Manson JE; Stefanick ML; Allison MA;
Circulation; 2020 Dec; 142(25):e506-e532. PubMed ID: 33251828
[TBL] [Abstract][Full Text] [Related]
22. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women.
Gast GC; Samsioe GN; Grobbee DE; Nilsson PM; van der Schouw YT
Maturitas; 2010 Jul; 66(3):285-90. PubMed ID: 20400247
[TBL] [Abstract][Full Text] [Related]
23. Trajectories of Vasomotor Symptoms and Carotid Intima Media Thickness in the Study of Women's Health Across the Nation.
Thurston RC; El Khoudary SR; Tepper PG; Jackson EA; Joffe H; Chen HY; Matthews KA;
Stroke; 2016 Jan; 47(1):12-7. PubMed ID: 26578657
[TBL] [Abstract][Full Text] [Related]
24. Ovarian hormones and obesity.
Leeners B; Geary N; Tobler PN; Asarian L
Hum Reprod Update; 2017 May; 23(3):300-321. PubMed ID: 28333235
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study.
El Khoudary SR; Shields KJ; Janssen I; Hanley C; Budoff MJ; Barinas-Mitchell E; Everson-Rose SA; Powell LH; Matthews KA
J Clin Endocrinol Metab; 2015 Sep; 100(9):3304-12. PubMed ID: 26176800
[TBL] [Abstract][Full Text] [Related]
26. Menopause: Hormones, Lifestyle, and Optimizing Aging.
Minkin MJ
Obstet Gynecol Clin North Am; 2019 Sep; 46(3):501-514. PubMed ID: 31378291
[TBL] [Abstract][Full Text] [Related]
27. Androgens and estrogens in relation to hot flushes during the menopausal transition.
Øverlie I; Moen MH; Holte A; Finset A
Maturitas; 2002 Jan; 41(1):69-77. PubMed ID: 11809345
[TBL] [Abstract][Full Text] [Related]
28. What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause.
Rossmanith WG; Ruebberdt W
Gynecol Endocrinol; 2009 May; 25(5):303-14. PubMed ID: 19903037
[TBL] [Abstract][Full Text] [Related]
29. Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes.
Park SK; Harlow SD; Zheng H; Karvonen-Gutierrez C; Thurston RC; Ruppert K; Janssen I; Randolph JF
Diabet Med; 2017 Apr; 34(4):531-538. PubMed ID: 27973745
[TBL] [Abstract][Full Text] [Related]
30. Trajectories of Blood Pressure in Midlife Women: Does Menopause Matter?
Samargandy S; Matthews KA; Brooks MM; Barinas-Mitchell E; Magnani JW; Thurston RC; El Khoudary SR
Circ Res; 2022 Feb; 130(3):312-322. PubMed ID: 35113663
[TBL] [Abstract][Full Text] [Related]
31. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN).
Luetters C; Huang MH; Seeman T; Buckwalter G; Meyer PM; Avis NE; Sternfeld B; Johnston JM; Greendale GA
J Womens Health (Larchmt); 2007 Apr; 16(3):331-44. PubMed ID: 17439378
[TBL] [Abstract][Full Text] [Related]
32. 'Feeling hot, hot, hot': is there a role for exercise in the management of vasomotor and other menopausal symptoms?
Daley AJ; Stokes-Lampard H; MacArthur C
J Fam Plann Reprod Health Care; 2007 Jul; 33(3):143-5. PubMed ID: 17609065
[No Abstract] [Full Text] [Related]
33. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study.
Woods NF; Mitchell ES; Tao Y; Viernes HM; Stapleton PL; Farin FM
Menopause; 2006; 13(6):902-10. PubMed ID: 16977255
[TBL] [Abstract][Full Text] [Related]
34. Change in psychological and vasomotor symptom reporting during the menopause.
Hardy R; Kuh D
Soc Sci Med; 2002 Dec; 55(11):1975-88. PubMed ID: 12406465
[TBL] [Abstract][Full Text] [Related]
35. Trauma and its implications for women's cardiovascular health during the menopause transition: Lessons from MsHeart/MsBrain and SWAN studies.
Thurston RC
Maturitas; 2024 Apr; 182():107915. PubMed ID: 38280354
[TBL] [Abstract][Full Text] [Related]
36. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
37. Role of Estrogens in the Regulation of Liver Lipid Metabolism.
Palmisano BT; Zhu L; Stafford JM
Adv Exp Med Biol; 2017; 1043():227-256. PubMed ID: 29224098
[TBL] [Abstract][Full Text] [Related]
38. Vasomotor symptoms and cardiometabolic risk factors in menopausal women: a MONET Group study.
Abdulnour J; Stacey D; Dionne IJ; Brochu M; Doucet É; Prud'homme D
Climacteric; 2016 Aug; 19(4):381-6. PubMed ID: 27294579
[TBL] [Abstract][Full Text] [Related]
39. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk.
Allison MA; Manson JE
Menopause; 2009; 16(4):619-20. PubMed ID: 19503007
[No Abstract] [Full Text] [Related]
40. Vasomotor menopausal symptoms and cardiovascular disease risk in midlife: A longitudinal study.
Dam V; Dobson AJ; Onland-Moret NC; van der Schouw YT; Mishra GD
Maturitas; 2020 Mar; 133():32-41. PubMed ID: 32005421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
